This study aimed to assess the characteristics, utilization of antihyperglycemic drugs, and to analyze the quality of life (QOL) in type 2 diabetes mellitus (T2DM) patients. This two-month prospective descriptive cross-sectional study was undertaken by distributing the European Quality of Life -5 Dimensions 3 Level (EQ-5D-3L) questionnaire to the patients with T2DM (n=50) admitted to Helvetia primary health center Medan to assessed their QOL. The patients" characteristics and the utilization of antihyperglycemic drugs were assessed from the patients" medical records using a self-designed questionnaire. The inclusion criteria were T2DM patients with age of 18 years or older, had no mental disorders, and agreed to sign the informed consent. The patients" characteristics, their QOL, utilization of antihyperglycemic drugs, and association among their characteristics and QOL were analyzed using descriptive and Chi-Square tests. All analyses were performed using the Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) (p value <0.05 was considered significant). It was found that the mean age of the T2DM patients was 59.70 ± 10.44 (years). Most (66%) of them were females. Majority (80%) of the patients graduated from primary to senior high schools. Nearly half (44%) of the patients was provided glibenclamide. The mean QOL of the patients was 0.79 ± 0.14. There was no significant association between the patients" QOL and their characteristics (p values >0.05). This study proved that most of the T2DM patients were females. Glibenclamide was the most frequently prescribed drug for the patients. The QOL of the patients was 79% of full health.
Introduction
Diabetes mellitus (DM) remains as a global public health problem with continued increasing prevalence in developed as well as developing countries, including Indonesia. The disease contributed to 1.5 million of deaths worldwide in 2012. According to World Health Organization (WHO), the global prevalence of diabetes has nearly doubled since 1980, rising from 4.7% to 8.5% in 2014. The number of adults with DM in 2014 reached 422 million compared to those in 1980 was only 108 million. In Indonesia, it was found that 99,400 incidences of death in patients with diabetes out of 258 million of the population. The disease contributed to 6% of the overall mortality in 2014 [1] .
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia associated with abnormalities in the metabolism of carbohydrates, fats and proteins caused by decreased insulin secretion, decreased insulin activity or both which ultimately causes multiple medical complications, including nephropathy, retinopathy with potential blindness, neuropathy, gastrointestinal symptoms, amputation, impotence, symptomatic hyperglycemia, and hypoglycemia [2] . These conditions have resulted in reduced QOL and work productivity, which even finally leads to lower life expectancy. The disease will accompany the patient"s lifetime and worsen over time if not treated properly [3] . Many complicated factors are associated with the QOL in patients with T2DM including age, gender, educational level, socioeconomic status, the disease duration, long-term multiple complications of DM, ability of the patients to cope with her or his diseases, and the provided health cares. These issues are the challenges of the health care systems in the international as well as national level [4, 5] .
Varieties of health care programs in the management of DM have been implemented in different parts of the world. Yet, the health care programs should always be evaluated, analyzed, and improved in optimizing the scarce health resources and the public demand for health services. A pharmacoeconomic study plays a crucial role to evaluate the health care programs in the treatment of DM. One of the most important issues in this area is how to measure, value and incorporate changes in QOL into the economic evaluation. Therefore, the QOL as an outcome measure in the management of patients with T2DM must be studied [6] .
Many studies on QOL in T2DM patients with different methods and extents have been undertaken by researchers elsewhere. A large scale study had been undertaken to characterize the impact of hypoglycemia on diabetes burden, QOL, and work productivity from the patients" perspective. This study indicated that hypoglycemia negatively impacts social function, overall QOL, and work productivity [3] . Another study on QOL using WHO Diabetes Treatment Satisfaction Questionnaire (DTSQ) in patients with T2DM (n=180) conducted in a primary health center in Turkey found that their score was 21.02 ± 8.07 (range from better to worse: 36 to 0) for the entire group [7] . Additionally, in a cross-sectional study, QOL of 183 patients with T2DM was analyzed using a questionnaire called the Audit of Diabetes Dependent Quality of Life (ADDQoL). It was indicated that the mean score of the patients" QOL was 0.98 ± 0.89 [8] .
The characteristics of the patients with T2DM vary from one country to another due to differences in social economics status and health care systems which ultimately require different policies and approaches to optimize the disease management.
In relation to the problems previously described, the present study was undertaken to assess the characteristics, utilization of antihyperglycemic drugs, and QOL inT2DM patients admitted to Helvetia primary health center.
Methods
This two-month prospective descriptive cross-sectional study was undertaken to access the characteristics, utilization of antihyperglycemic drugs and the QOL of patients with T2DM (n=50) admitted to Helvetia primary health center in Medan. This health center is included into one of the big five health centers with high patients" admission in this city. Thus, this center was chosen as the location of the study. The target population in this study was all patients suffered from T2DM admitted to Helvetia primary health center period June-July 2015. Patients with T2DM age 18 years or older, showed no mental disorder, and agreed to sign the inform consent were included into this study. The study was approved by Health Research Ethical Committee, Faculty of Medicine, University of Sumatera Utara, Indonesia. A self-designed questionnaire was used to access the patients" characteristics including gender, age, education, occupation, duration of the disease, complications and utilization of antihyperglycemic drugs from the patients" medical records.The QOL of each of the patients was assessed using EQ5D3L questionnaireas an instrument filled out by the patients with T2DM under the direction of the researchers [9] . The QOL of the patients assessed consisted of 5 dimensions including the patients" mobility, self care, usual activity, pain/discomfort and anxiety/depression). Each of the 5 dimensions was categorized into 3 levels known as 3L (1= no problem, 2 = there is a bit problem, and 3 = there is a serious problem).The preferences of each patient were expressed as index value ranging from 11111 (full health or 100%) to 33333 (worst health or zero) using the EQ5D value set [9] . The patients" characteristics and mean value of their QOL were descriptively analyzed. The scores of the patients" QOL were categorized into three grades (≥0.8 = good, <0.8-0.6 = fair, <0.6 = bad). Association among their characteristics and their QOL were analyzed using cross-tabulation Chi-Square test. All analyses were performed using the Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) (p value <0.05 was considered significant).
Results
In this study, there were 50 patients with T2DM recruited from the Helvetia health center period June-July 2015 that met the inclusion criteria. Characteristics of the patients with T2DM admitted to the primary health center are shown in Table Only 20% of them graduated from universities. With regard to occupation, nearly half (48%)of the patients were housewives. The rest of the T2DM patients were pensionary (20%), enterprisers (18%), officials (8%), and teachers (6%). By duration of the disease, it was found that most of the patients (70%) have suffered from the disease for 0-10 years. Less than one third (28%) of them had suffered from the disease for 10-20 years. Only 2% of them had suffered from the disease for more than 20 years. As much as 42% of the patients had no complications and more than half (58%) of them suffered from complications (58%). The utilization of antihyperglycemic drugs in the management of patients with T2DM at the Helvetia health center period June to July 2015 is listed in Table 2 . As listed in Table 2 , the rank of antihyperglycemic drugs provided to the patients with T2DM in decreasing order were glibenclamide (44%), glibenclamide-metformin (18%), glimepiride (16%), metformin (12%), glimepiride-metformin(6%), glimepiride-glibenclamide (2%), and prodiabet-metformin (2%).
The QOL of the patients with T2DM is demonstrated in Table 3 . Overall, mean value of the QOL of the patients with T2DM was 0.79 ± 0.14. There were only 8 patients had perfect QOL.
Five patients had QOL of 0.85. Majority (18) of the patients had the QOL dimensions of 11121 with a score of 0.80. Thus, only 31 (62%) of them had good QOL. Eighteen (36%) of them had fair QOL. One (2%) of the patients had bad QOL. Table 3 is the association between the age of the patients with T2DM and their QOL.
It was proved that the QOL of the patients with T2DM was different in each age level.The present study found that there was no significant difference between the QOL of males and those of females, p = 0.325. It was also proved that there was no significant association between the age of the patients and their QOL, p = 0.620. In other words, the age of the patients with T2DM did not affect their QOL. The QOL of the patients with T2DM was not associated with their educations, p = 0.377. By occupation, the present study proved that there were no significant differences in QOL among the five groups of patients, p = 0.155. This study also indicated that there were no significant association among the duration of the disease and the QOL of the patients with T2DM, p = 0.596. Result of statistical analysis also proved that there was no significant difference in the average value of the QOL between patients with and without complications, p = 0.446.
Complications that may affect the QOL of patients with T2DM include increased blood cholesterol, hypertension, urinary tract infection, cardiovascular disease, nephropathy, retinopathy, and neuropathy.
Discussions
The present study found that the age of the T2DM patients was 59.70 ± 10.44 (years). Most of them (66%) were females. This result was not consistent with the sex ratio of the total Indonesian population which is 101.42 males per 100 females of the same year [10] .
Additionally, a study proved that females were more prone to develop diabetes because they have a greater chance to increase body mass index compared to males. Also, monthly premenstrual cycle syndrome and post-menopausal ease the fat accumulate in the body as a result of the hormonal process. These conditions tend to cause higher risk (53.2%) for developing T2DM in females compared to males [11] . A study undertaken in the US also proved that body mass index is a substantial contributor to the increase in the prevalence of diabetes [12] . A large-scale prospective cohort study conducted in Spain also proved that the incidence of T2DM increased with the increasing incidence of obesity [13] .
By age, most of the T2DM patients were at the age range of 56-65 years and older. This finding is consistent with the statement of the American Diabetes Association, that people at the age of 45 years or older have a high risk to developT2DM [14] . Aging affects many hormones that regulate metabolism, reproduction and other body functions. Aging affects the pancreatic β cell sensitivity to glucose and delay the mediationof glucose uptake by insulin into the cells [15] .
Four of the most frequently provided antihyperglycemic drugs provided to the patients with T2DM with decreasing order were glibenclamide, glibenclamide-metformin, glimepiride and metformin. Glibenclamide is included into sulfonylurea class whose mechanism of action to increase insulin secretion by pancreatic beta cells so as to have a hypoglycemic effect. This drug is an option for adult patients with DM with normal weight who have never experienced ketoacidosis. A previous study conducted in a tertiary care teaching hospital in Eastern India indicated that the most widely used antihyperglycemic agent was biguanide followed by sulfonylureas [16] . Another study proved that the most widely used antihyperglycemic agent was metformin followed by sulfonylurea class of drugs [17] . These studies indicated that the utilization of antihyperglycemic agents vary from one country to another.
The present study found that the index of QOL of patients with T2DM was 0.79. There were limited similar studies conducted in Indonesia. A QOL study conducted on Brunai Malay T2DM patients (n=154) applying EQ5D5L found that the index of their QOL was 0.626 [18] .
The QOL of patients with T2DM is an important and measurable outcome of healthcare interventions. It should be considered by policy-makers to prioritize the use of health resources.
It was found in this study that the QOL of the patients was not associated with their education.
In fact, only 20% of them graduated from universities. This is probably the reason why there was no association between the patients" education and their QOL. The level of education can affect the patients" insight in understanding the disease, self-care and lifestyle settings. In addition, the highly educated patients can easily develop a good understanding of information.
These individuals will positively respond the information and take appropriate action for themselves [5] . An ancillary observational analysis of a four-year randomized controlled trial on T2DM patients had greater remission compared with an intensive lifestyle intervention (ILI) with a diabetes support and education control condition (DSE) among 4503 US adults [19] .
The duration of the disease by age groups of the patients was not associated with their QOL. In contrast to this study, previous finding indicated that the risk for complications in patients with DM was associated with the duration of the disease. The main risk factors for developing complications in diabetic patients were the duration and severity of the disease. Efforts to improve the QOL are important to prevent from long-term complications [20] .The present study proved that there was no significant association between the age of the patients with T2DM and their QOL.
This study proved that gender was not associated with the QOL of the patients with T2DM. A similar study also confirmed that there was no significant difference in the QOL of males and those of females [21] . Adherence to pharmacological and non pharmacological therapies contributes to improve the QOL of patients with T2DM. Females usually have better adherence to their treatments, thus, the treatment implementation usually goes on better in females compared to males. However, males tend to have higher self confidence and the ability to cope with the disease they suffer. Ultimately, gender was not associated with the level of QOL [21] .
It was also proved that occupation, the disease duration, and age groups of the patients were not associated with their QOL.This study also indicated that there was no significant difference in the average value of the QOL between patients with and without complications. In contrast to this study, a finding proved that the complications experienced by the T2DM patients resulted in physical, psychological and even social limitations which ultimately lead to poor QOL [21] .
Conclusions
Most of the patients with T2DM were females with varies age ranging from 36 years to older than 65 years. Glybenclamide was the most widely provided antihyperglycemic drug to the patients with T2DM. The QOL of the patients was only 79% of full health. The most frequently observed dimensions of 11121 with a score of 0.80. The QOL of the patients was not associated with age, gender, education, occupation, complications as well as the disease duration.
This study was limited by the small sample size and period of the patients" admission from which data were extracted. In the future a large-scale study is required to get more accurate results.
